GB1511820A - 16-methyl-9alpha-halo steroid ethers and esters and their preparation - Google Patents
16-methyl-9alpha-halo steroid ethers and esters and their preparationInfo
- Publication number
- GB1511820A GB1511820A GB47940/77A GB4794077A GB1511820A GB 1511820 A GB1511820 A GB 1511820A GB 47940/77 A GB47940/77 A GB 47940/77A GB 4794077 A GB4794077 A GB 4794077A GB 1511820 A GB1511820 A GB 1511820A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acyl
- valerate
- acetate
- methyl
- trifluoroacetate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 -halo steroid ethers Chemical class 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000002148 esters Chemical class 0.000 title 1
- 125000002252 acyl group Chemical group 0.000 abstract 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract 6
- 229940070710 valerate Drugs 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000003776 cleavage reaction Methods 0.000 abstract 3
- 230000007017 scission Effects 0.000 abstract 3
- 238000003797 solvolysis reaction Methods 0.000 abstract 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000741 silica gel Substances 0.000 abstract 2
- 229910002027 silica gel Inorganic materials 0.000 abstract 2
- 229960001866 silicon dioxide Drugs 0.000 abstract 2
- 125000004187 tetrahydropyran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 2
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- NGXUUAFYUCOICP-UHFFFAOYSA-N aminometradine Chemical group CCN1C(=O)C=C(N)N(CC=C)C1=O NGXUUAFYUCOICP-UHFFFAOYSA-N 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940051868 antimigraine drug corticosteroid derivative Drugs 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical class C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 abstract 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical class C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000006192 iodination reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
- C07J7/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16
- C07J7/0055—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT6163674 | 1974-03-27 | ||
| PT6163774 | 1974-03-27 | ||
| PT6163675 | 1975-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1511820A true GB1511820A (en) | 1978-05-24 |
Family
ID=27354092
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB12608/75A Expired GB1510617A (en) | 1974-03-27 | 1975-03-26 | 16-methyl-9alpha-halo steroid esters and ethers and preparation thereof |
| GB47940/77A Expired GB1511820A (en) | 1974-03-27 | 1975-03-26 | 16-methyl-9alpha-halo steroid ethers and esters and their preparation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB12608/75A Expired GB1510617A (en) | 1974-03-27 | 1975-03-26 | 16-methyl-9alpha-halo steroid esters and ethers and preparation thereof |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE827275A (de) |
| CH (2) | CH622811A5 (de) |
| DK (1) | DK153556C (de) |
| FR (1) | FR2274309A1 (de) |
| GB (2) | GB1510617A (de) |
| IE (2) | IE41138B1 (de) |
| NZ (1) | NZ177056A (de) |
| SE (1) | SE440656B (de) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866051A (en) * | 1981-10-19 | 1989-09-12 | Glaxo Group Limited | Micronised beclomethasone dipropionate monohydrate compositions and methods of use |
| CN102516348A (zh) * | 2011-11-10 | 2012-06-27 | 中国科学院上海有机化学研究所 | 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1285770B1 (it) | 1996-10-04 | 1998-06-18 | Nicox Sa | Composti corticoidei |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1070751A (en) * | 1964-01-28 | 1967-06-01 | Glaxo Lab Ltd | 17-esters of 17-hydroxy-21-desoxy-steroids |
| GB1139505A (en) * | 1965-06-23 | 1969-01-08 | Glaxo Lab Ltd | A process for the production of 17-‡-monoesters of 17-‡-hydroxy-20-keto-steroids |
| CH481085A (de) * | 1965-08-30 | 1969-11-15 | Scherico Ltd | Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe |
| US3383394A (en) * | 1965-08-30 | 1968-05-14 | Schering Corp | Novel 17-acylating process and products thereof |
| BE788355A (fr) * | 1971-09-07 | 1973-03-05 | Merck Patent Gmbh | Esters de 9 alpha-fluoro-16-methylene-prednisolone |
-
1975
- 1975-03-26 CH CH392475A patent/CH622811A5/de not_active IP Right Cessation
- 1975-03-26 DK DK129575A patent/DK153556C/da not_active IP Right Cessation
- 1975-03-26 GB GB12608/75A patent/GB1510617A/en not_active Expired
- 1975-03-26 NZ NZ177056A patent/NZ177056A/xx unknown
- 1975-03-26 GB GB47940/77A patent/GB1511820A/en not_active Expired
- 1975-03-27 BE BE154849A patent/BE827275A/xx not_active IP Right Cessation
- 1975-03-27 IE IE2062/75A patent/IE41138B1/xx unknown
- 1975-03-27 FR FR7509621A patent/FR2274309A1/fr active Granted
- 1975-03-27 IE IE693/75A patent/IE41137B1/xx unknown
-
1978
- 1978-03-16 SE SE7803041A patent/SE440656B/sv not_active IP Right Cessation
-
1979
- 1979-10-22 CH CH946879A patent/CH625254A5/de not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4866051A (en) * | 1981-10-19 | 1989-09-12 | Glaxo Group Limited | Micronised beclomethasone dipropionate monohydrate compositions and methods of use |
| CN102516348A (zh) * | 2011-11-10 | 2012-06-27 | 中国科学院上海有机化学研究所 | 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途 |
| CN102516348B (zh) * | 2011-11-10 | 2013-11-13 | 中国科学院上海有机化学研究所 | 一种16s-甲基-20s-羟基孕甾化合物、合成方法及其用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2274309A1 (fr) | 1976-01-09 |
| IE41137B1 (en) | 1979-10-24 |
| NZ177056A (en) | 1978-09-20 |
| DK153556B (da) | 1988-07-25 |
| DK129575A (de) | 1975-09-28 |
| CH622811A5 (de) | 1981-04-30 |
| BE827275A (fr) | 1975-07-16 |
| IE41137L (en) | 1975-09-27 |
| FR2274309B1 (de) | 1978-11-24 |
| SE7803041L (sv) | 1978-03-16 |
| IE41138B1 (en) | 1979-10-24 |
| SE440656B (sv) | 1985-08-12 |
| CH625254A5 (de) | 1981-09-15 |
| GB1510617A (en) | 1978-05-10 |
| DK153556C (da) | 1988-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4124707A (en) | 7α-Halogeno-3,20-dioxo-1,4-pregnadienes, methods for their manufacture, their use as anti-inflammatory agents, and pharmaceutical formulations useful therefor | |
| US4267173A (en) | Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor | |
| US3943124A (en) | Chemical compounds | |
| US4290962A (en) | Novel hydrocortisone derivative | |
| US4172132A (en) | 1,3,5(10),6,8,14-19-Nor-pregnahexaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| GB1429184A (en) | Physically anti-inflammatory steroids for use in aerosols | |
| JPS6069019A (ja) | 局所抗炎症用薬剤組成物 | |
| US4036831A (en) | Trimethyl siloxane steroid intermediates | |
| US4910192A (en) | Topically active steroidal anti-inflammatory agents | |
| GB1380246A (en) | 3alpha-hydroxy-androstanes and esters thereof | |
| US3984544A (en) | Retinoic acid esters of steroids of the pregnane series, their use in the treatment of acne and pharmaceutical formulations useful therefor | |
| GB1511820A (en) | 16-methyl-9alpha-halo steroid ethers and esters and their preparation | |
| US4296109A (en) | Corticoid 21-sulfopropionates and the salts thereof, a process for the production thereof and pharmaceutical preparations thereof | |
| US4024131A (en) | 16-Methyl-9α-halo steroid esters, ethers and preparation thereof | |
| US4318853A (en) | 9β,11β-Epoxy-5β-corticoids | |
| GB1376892A (en) | 2beta-substituted-3alpha-hydroxysteroids and their esters | |
| EP0072200B1 (de) | Steroidesters und Verfahren zur Herstellung von Steroidesters | |
| HU203562B (en) | Process for producing new steroide diols and pharmaceutical compositions containing them | |
| US3206359A (en) | Galacturonides of the anti-inflammatory pregnane series | |
| US4427591A (en) | Reduced A ring-Δ9(11) -corticoids | |
| US3969345A (en) | 20β,21-Epoxy-3α-hydroxy-5α-pregnanes and derivatives thereof | |
| GB1458517A (en) | 21-sulphinyl steroids | |
| US4185101A (en) | 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor | |
| US3714353A (en) | THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES | |
| EP0170500B1 (de) | 9-Alpha-Fluor- oder Chlor-Corticosteroide und Verfahren zu ihrer Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 19950325 |